US demand for nanotechnology medical products will grow 17.5 percent annually through 2011, driven by the critical need for new or improved therapies and diagnostics. The greatest short-term impact will be in cancer and central nervous system disorders, followed by orthopedic nanoimplants.
This study analyzes the $23.6 billion US nanotech medical product industry to 2011, 2016 and 2021 by nanomaterial (e.g., monoclonal antibodies, DNA, nanoparticles, nanotubes and nanowires), by product (e.g,. nanomedicines, nanodiagnostics, supplies and devices), and by application (e.g., cancer, central nervous system conditions, infective and parasitic conditions).
The study also considers market environment factors, reviews product development activities, evaluates company market share and profiles 69 major players including Genentech, Johnson & Johnson, Abbott Laboratories, Amgen, and Roche.